Journal article : Review
The PD-1/PD-L1 checkpoint in normal germinal centers and diffuse large B-cell lymphomas
- Abstract:
- Besides a recognized role of PD-1/PD-L1 checkpoint in anti-tumour immune evasion, there is accumulating evidence that PD-1/PD-L1 interactions between B and T cells also play an important role in normal germinal center (GC) reactions. Even when smaller in number, T follicular helper cells (TFH) and regulatory T (TFR) or B (Breg) cells are involved in positive selection of GC B cells and may result critical in the lymphoma microenvironment. Here, we discuss a role of PD-1/PD-L1 during tumour evolution in diffuse large B cell lymphoma (DLBCL), a paradigm of GC-derived lymphomagenesis. We depict a progression model, in two phases, where malignant B cells take advantage of positive selection signals derived from correct antigen-presentation and PD-1/PD-L1 inter-cellular crosstalks to survive and initiate tumour expansion. Later, a constant pressure for the accumulation of genetic/epigenetic alterations facilitates that DLBCL cells exhibit higher PD-L1 levels and capacity to secrete IL-10, resembling Breg-like features. As a result, a complex immunosuppressive microenvironment is established where DLBCL cells sustain proliferation and survival by impairing regulatory control of TFR cells and limiting IL-21-mediated anti-tumour functions of TFH cells and maximize the use of PD-1/PD-L1 signaling to escape from CD8+ cytotoxic activity. Integration of these molecular and cellular addictions into a framework may contribute to the better understanding of the lymphoma microenvironment and contribute to the rationale for novel PD-1/PD-L1-based combinational immunotherapies in DLBCL.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.7MB, Terms of use)
-
- Publisher copy:
- 10.3390/cancers13184683
Authors
+ Departamento de Educación, Gobierno de Navarra
More from this funder
- Funder identifier:
- https://ror.org/025qq4838
- Grant:
- 34E/2020
- Publisher:
- MDPI
- Journal:
- Cancers More from this journal
- Volume:
- 13
- Issue:
- 18
- Article number:
- 4683
- Place of publication:
- Switzerland
- Publication date:
- 2021-09-18
- Acceptance date:
- 2021-09-13
- DOI:
- EISSN:
-
2072-6694
- Pmid:
-
34572910
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
2119627
- Local pid:
-
pubs:2119627
- Deposit date:
-
2025-04-24
- ARK identifier:
Terms of use
- Copyright holder:
- Garcia-Lacarte et al
- Copyright date:
- 2021
- Rights statement:
- © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record